WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007090887) 3, 9-DIAZABICYCLO [3.3. 1]NONANE DERIVATIVES AND THEIR USE AS MONOAMINE?NEUROTRANSMITTER RE-UPTAKE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/090887    International Application No.:    PCT/EP2007/051271
Publication Date: 16.08.2007 International Filing Date: 09.02.2007
IPC:
C07D 471/08 (2006.01), C07D 519/00 (2006.01), A61K 31/4995 (2006.01)
Applicants: NEUROSEARCH A/S [DK/DK]; 93 Pederstrupvej, DK-2750 Ballerup (DK) (For All Designated States Except US).
PETERS, Dan [SE/DK]; (DK) (For US Only).
REDROBE, John, Paul [GB/DK]; (DK) (For US Only).
NIELSEN, Elsebet, Østergaard [DK/DK]; (DK) (For US Only)
Inventors: PETERS, Dan; (DK).
REDROBE, John, Paul; (DK).
NIELSEN, Elsebet, Østergaard; (DK)
Common
Representative:
NEUROSEARCH A/S; Patent Department, 93 Pederstrupvej, DK-2750 Ballerup (DK)
Priority Data:
PA 2006 00191 10.02.2006 DK
60/771,889 10.02.2006 US
Title (EN) 3, 9-DIAZABICYCLO [3.3. 1]NONANE DERIVATIVES AND THEIR USE AS MONOAMINE?NEUROTRANSMITTER RE-UPTAKE INHIBITORS
(FR) DÉRIVÉS DE 3, 9-DIAZABICYCLO [3.3. 1]NONANE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE RÉABSORPTION DE NEUROTRANSMETTEUR DE MONOAMINE
Abstract: front page image
(EN)This invention relates to novel 3,9-diazabicyclo[3.3.1 ]nonane derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
(FR)L'invention concerne des nouveaux dérivés de 3, 9-diazabicyclo [3.3. 1]nonane utiles en tant qu'inhibiteurs de réabsorption de neurotransmetteur de monoamine. D'autres aspects de l'invention concernent l'utilisation desdits composés dans une méthode thérapeutique et des compositions pharmaceutiques comprenant lesdits composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)